• Free Consultation
  • Products
    • LighthouseAI
    • NavigateSOM
      • About
      • Features & Capabilities
      • Implementation
  • Services
    • State Licensing
    • Assessments & Custom Research
    • Certification, Credentialing & Accreditation
      • NABP Drug Distributor Accreditation
      • Pharmacy Accreditations
    • Regulatory Affairs
      • Puerto Rico Regulatory Filings
      • DEA Consulting
      • State Inspection Preparation
      • Policy & Procedure Development
    • Fingerprinting
    • Training
      • Designated Representative Courses
  • Customers
    • 503A
    • 503B
    • Healthcare Providers
    • Manufacturer
    • Pharmacy
    • Repackager
    • Reverse Distributors
    • Third-Party Logistics Provider (3PL)
    • Virtual Manufacturer (VM)
    • Wholesale Distributor (WDD)
  • About Us
    • About the Company
    • About Our Team
    • Careers
    • Testimonials
  • Resources
    • Webinars
    • Whitepapers
  • Blog
  • Subscribe
  • Contact Us
FDA Authorizes Florida’s Drug Importation Program

FDA Authorizes Florida’s Drug Importation Program

by James DeFranco | Jan 9, 2024 | Uncategorized

FDA Authorizes Florida’s Drug Importation Program  | by: Deneen Fumich, RPh | Article Posted: January 9, 2024 | The U.S. Food and Drug Administration approves the first state request to import drugs from Canada. Announced on January 5th, the FDA has authorized...
FDA Warning on Xylazine: Mitigating Human Risk

FDA Warning on Xylazine: Mitigating Human Risk

by James DeFranco | Nov 6, 2023 | Uncategorized

FDA Warning on Xylazine: Mitigating Human Risk  | by: Sumeet Singh, Founder & Chairman | Article Posted: November 6, 2023 | The U.S. Food and Drug Administration (FDA) has issued a warning regarding mitigating risks from human Xylazine exposure. FDA has not...
Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know 

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know 

by James DeFranco | Nov 6, 2023 | Uncategorized

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know   | by: Sumeet Singh, Founder & Chairman | Article Posted: November 6, 2023 | In recent years, the transparency surrounding prescription drug pricing has become a focal...
Important Updates from the Alabama Board of Pharmacy on Facility Applications and Renewals

Important Updates from the Alabama Board of Pharmacy on Facility Applications and Renewals

by James DeFranco | Oct 26, 2023 | Uncategorized

FDA Important Updates from the Alabama Board of Pharmacy on Facility Applications and Renewals  | by: Sumeet Singh, Founder & Chairman | Article Posted: October 26, 2023 | The Alabama Board of Pharmacy has recently made an announcement that affects companies...
FDA Extends Enforcement Deadline for Drug Supply Chain Security Act (DSCSA) Requirements

FDA Extends Enforcement Deadline for Drug Supply Chain Security Act (DSCSA) Requirements

by James DeFranco | Sep 6, 2023 | Uncategorized

FDA Extends Enforcement Deadline for Drug Supply Chain Security Act (DSCSA) Requirements  | by: Sumeet Singh, Founder & Chairman | Article Posted: September 6, 2023 | Introduction  The U.S. Food and Drug Administration (FDA) recently announced an extension on the...
12345...>Last >

Pharma Solutions supports the drug and device supply chain by leveraging innovation and leading experts in the industry. Our commitment to providing purpose-built technology solutions, tailored consulting, and dedicated administrative support ensures our clients meet their business and compliance objectives

QUICK LINKS

  • Home
  • Free Consultation
  • Solutions
  • Customers
  • Company
  • Resources
  • Blog
  • Contact Us

CONTACT US

(484) 800-1863

hello@pharma.solutions

705 Montgomery Avenue, Suite 200 Penn Valley, PA 19072

Book Your FREE Consultation

© Copyright 2025 by Pharma Solutions USA, Inc. All Rights Reserved.